Impact of Anti-IgM on B-cell Development in Sheep
Author Information
Author(s): P. MCCULLAGH, C.MCL. PRESS, S.J. MCCLURE, H.J. LARSEN, T. LANDSVERK
Primary Institution: John Curtin School of Medical Research, Australian National University
Hypothesis
How does the timing and dosage of anti-IgM antibody administration affect B-cell development in foetal lambs?
Conclusion
The study found that the effectiveness of anti-IgM antibody in depleting B cells in foetal lambs depends on the timing and dosage of administration.
Supporting Evidence
- A single injection of anti-IgM at 63 days of gestation resulted in marked B-cell depletion.
- Weight-adjusted doses of anti-IgM extended the gestational age at which B-cell development could be disrupted.
- Splenectomy did not restore the capacity of anti-IgM to deplete B cells when administered at later gestational ages.
Takeaway
Giving a special antibody to baby sheep at the right time can stop their immune cells from growing, but if you wait too long, it won't work.
Methodology
Foetal lambs were injected with varying doses of anti-IgM antibody at different gestational ages, and their B-cell development was assessed.
Limitations
The study did not explore the effects of anti-IgM on developed ileal Peyer's patches or the long-term implications of B-cell depletion.
Participant Demographics
Foetal lambs of known gestational age from Merino ewes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website